Tracking the PRAX option chain helps you see every strike and expiry on Praxis Precision Medicines Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Praxis Precision Medicines Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PRAX options activity at a glance. Use our scanner to monitor the PRAX option chain in real time and filter for the PRAX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PRAX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PRAX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PRAX stock options are being actively traded and where they are not.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy.
It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Praxis Precision Medicines Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PRAX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PRAX stock options — let the full option chain come to you, pre-filtered and ready to trade.
